What is Lu PSMA (Lutetium-Prostate Specific Membrane Antigen) Therapy?

Lu177 PSMA Therapy is a treatment for patients with prostate cancer, especially those who have become refractory to conventional therapy. Lutetium PSMA therapy helps to slow down the growth of the cancer cells, reduce the size of the tumours and most importantly improve the quality of life of the patients by reducing the pain caused by the cancer.

Many prostate cancers, in particular those that have spread or become resistant to hormonal therapies, express a unique receptor on their cell surface called Prostate Specific Membrane Antigen (PSMA). When Prostate Cancer metastasizes i.e. spreads to other parts of the body, the PSMA receptor is expressed over the sites of metastases as well.

How does Lu PSMA Therapy Work?

Lutetium-177 is a radioactive substance that emits beta radiation, a destructive kind of radiation. Lutetium-177 is bound to a small peptide which attaches to the PSMA receptor expressed on the cancer cell surface. The Lutetium 177 – PSMA complex, thus attached to the prostate cancer cell, then emits killing radiation causing cell death of the cancer cell. Since the penetration of the emitted beta particle is very small, the surrounding normal cells are spared.

How is the Therapy Done?

Lu177 PSMA is administered intravenously. The patient is admitted to the hospital for 24 hours. A kidney function scan called a MAG3/EC scan is done prior to the administration of the Lu177 PSMA.

What are the Side Effects of Lu PSMA Therapy?

Lu177 PSMA is well tolerated. The most common side effects are a slightly dry mouth, fatigue and nausea. There may also be a slight fall in the white blood cells and platelets about 2 – 3 weeks after the Lu177 PSMA administration.

What is the Response Rate With Lu PSMA Therapy?

The response rates of Lu177 PSMA depend on the tumour biology of prostate cancer, the initial Gleason Score, the extent of disease and the responses to prior therapies. Typically, more than 70% of patients demonstrate a reduction in S. PSA and a shrinkage of tumours following Lu177 PSMA therapy.

When would the doctor consider using this Therapy?

Lu PSMA Therapy is a very specific therapy and is used for managing metastatic Prostate Cancer or when Prostate Cancer is no longer responsive to other types of treatment.

What are the Treatment Schedules with Lu PSMA Therapy?

Most patients undergo three-four treatment cycles at intervals of 8-12 weeks. The number of cycles and the interim duration may vary between individuals depending on the response and interim assessments.

Why should I choose the nuclear medicine therapy center at Fortis Memorial & Research Institute (FMRI), Gurugram (Haryana, India)?

The Nuclear Medicine Therapy Centre at FMRI was one of the first institutes to offer Radio-ligand Therapy with Lu PSMA, and today, the center receives patients from the country and from across the world.

Get a Second Opinion - Nuclear Medicine Therapy

A cancer diagnosis represents a profound moment of uncertainty. Gain clarity and confidence through a specialized Second Reading of your PET CT scan, provided by Theranostic Physicians Private Limited (TPPL), led by renowned Nuclear Medicine expert Dr. Ishita B Sen. Dr. Sen brings extensive experience in Nuclear Imaging and Nuclear Oncology, having conducted and overseen numerous diagnostic evaluations and treatment planning cases, making her a trusted authority in the precise interpretation of PET CT scans critical for oncology care. She currently serves as the Director and Head of the Department of Nuclear Medicine & Molecular Imaging at Fortis Memorial Research Institute (FMRI), Gurgaon, and has extensive experience specifically in PET CT imaging. Her background includes specialized training from premier international institutions such as Memorial Sloan Kettering Cancer Centre in New York, USA, and AIIMS in New Delhi, India, emphasizing her deep expertise and commitment to accurate diagnostic interpretations. Dr. Sen is recognized for her exceptional expertise in PET imaging and reporting, with extensive experience in precise diagnostic interpretations critical to effective cancer treatment.

In the immediate aftermath of a diagnosis, once the initial shock recedes and a quiet determination sets in, inevitable questions begin to arise—persistent, critical, and precise. Is this diagnosis accurate? Are we seeing the complete picture? Could a nuanced re-assessment lead to a more effective treatment path?

These questions are not rooted in skepticism but diligence. In the landscape of cancer treatment, every decision is pivotal. Research consistently indicates that obtaining a second opinion can alter diagnoses in approximately 15% of cases and significantly change treatment plans in nearly 37% of cases. Accuracy from the outset can mean the difference between uncertainty and successful treatment.

The TPPL Second Reading service is specifically crafted to address this crucial need. Our approach is focused and precise—it’s a specialized expert reassessment exclusively of your PET CT scan images, ensuring thorough and accurate diagnostic interpretations.

Why a Second Reading is Not Optional but Essential

TPPL’s Second Reading service is founded upon three core principles: independence, specialized expertise, and timely delivery.

1. Independent Expertise. An Opinion You Can Trust.

Our priority is the precision and integrity of your diagnostic evaluation. TPPL provides exclusively diagnostic interpretations, completely independent of treatment services. This eliminates potential conflicts of interest prevalent in hospital settings, where second opinions may be influenced by treatment acquisition goals. Our sole responsibility is to deliver accurate, evidence-based assessments of your PET CT scans.

2. Specialized Expert Team Led by Dr. Ishita B Sen

Each PET CT scan submitted for the Second Reading service undergoes a meticulous review by TPPL’s team of expert nuclear medicine specialists, under the guidance of Dr. Ishita B Sen. With years of specialized experience in advanced PET imaging and interpretation, Dr. Sen ensures every detail and subtlety in your scan is accurately assessed, providing unparalleled diagnostic precision and reliability.

3. Swift Clarity, Delivered within 72 Hours.

Extended uncertainty should not compound the stress of a diagnosis. Our streamlined, secure digital process guarantees a detailed, actionable report within 72 hours. Simply submit your PET CT scans securely through our online portal from the comfort of your home. Your comprehensive report, professionally prepared and digitally secured, is swiftly delivered and ready for your treating physician’s immediate reference.

How It Works: Your Path to Certainty

We’ve designed the process to be straightforward, secure, and respectful of patient confidentiality.

Step 1: Secure Upload.

Complete our confidential online form with relevant patient information and clinical details, uploading your existing PET CT scan images and reports. We ensure stringent adherence to data protection standards.

Step 2: Expert Team Review

Upon submission, Dr. Ishita B Sen and the TPPL expert team rigorously evaluate your PET CT scans, seeking essential diagnostic details that can profoundly influence your treatment plan.

Step 3: Actionable Report Delivered

Within 72 hours, receive a comprehensive Second Reading report via secure, digitally signed PDF. This medical document provides clarity and actionable insights, empowering informed discussions and precise treatment decisions.

Take Control of Your Diagnosis

A precise diagnosis marks the beginning of an effective treatment journey. Empower yourself and your loved ones with TPPL’s expert-led PET CT Second Reading service, ensuring peace of mind and the confidence required to make informed, definitive treatment decisions.

The Right Treatment Begins with the Right Diagnosis. Are You Certain You Have It?